Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Coffin-Lowry syndrome is a rare genetic disorder caused by mutations in the RPS6KA3 gene, which provides instructions for making a protein essential for cell signaling and brain development. These mutations are inherited in an X-linked dominant pattern, meaning a single altered copy of the gene is sufficient to cause the condition in both males and females. What causes Coffin-Lowry syndrome at a genetic level? Coffin-Lowry syndrome is caused by pathogenic variants (mutations) in the RPS6KA3 gene located on the X chromosome.
TL;DR: Coffin-Lowry syndrome is a rare genetic disorder caused by mutations in the RPS6KA3 gene, which provides instructions for making a protein essential for cell signaling and brain development. These mutations are inherited in an X-linked dominant pattern, meaning a single altered copy of the gene is sufficient to cause the condition in both males and females.
Coffin-Lowry syndrome is caused by pathogenic variants (mutations) in the RPS6KA3 gene located on the X chromosome. This gene encodes a protein known as RSK2, which acts like a biological "relay switch" within cells. In a healthy body, the RSK2 protein helps transmit signals that regulate gene expression, cell growth, and the survival of neurons. When the RPS6KA3 gene is mutated, the RSK2 protein is either non-functional or missing entirely. This disrupts the intricate communication pathways within the brain, leading to the characteristic neurodevelopmental and skeletal features of Coffin-Lowry syndrome.
Yes, Coffin-Lowry syndrome follows an X-linked dominant inheritance pattern. Because the RPS6KA3 gene is located on the X chromosome, the inheritance dynamics differ between sexes:
Current medical literature indicates that Coffin-Lowry syndrome is strictly a genetic condition. There are no known environmental triggers, such as infections, toxins, or dietary factors, that cause this syndrome. It is important for families to understand that nothing done during pregnancy—or during the child's life—causes the underlying genetic mutation. The condition is established at the moment of conception, either through inheritance or a new (de novo) genetic event.
In the study of Coffin-Lowry syndrome, "cause" refers specifically to the RPS6KA3 mutation. There are no external "risk factors" that increase the likelihood of a child being born with the condition. While researchers continue to investigate why spontaneous mutations occur in the germ cells (sperm or egg), there is no evidence that parental age, lifestyle, or geography influences the risk of a child developing Coffin-Lowry syndrome.
Medical researchers are currently focused on understanding how the loss of RSK2 protein function affects specific cellular pathways, particularly the MAPK/ERK pathway. By mapping these pathways, scientists hope to develop future targeted therapies that could potentially bypass the blocked signals. Within the DiseaseMaps.org community, 84 people with Coffin-Lowry syndrome have shared their experiences, providing valuable real-world data that helps researchers correlate specific genetic mutations with clinical outcomes and symptom severity.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.